GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » Cyclically Adjusted FCF per Share

Penumbra (MEX:PEN) Cyclically Adjusted FCF per Share : MXN1.10 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Penumbra Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Penumbra's adjusted free cash flow per share for the three months ended in Mar. 2025 was MXN18.546. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN1.10 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-07-09), Penumbra's current stock price is MXN4911.82. Penumbra's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN1.10. Penumbra's Cyclically Adjusted Price-to-FCF of today is 4,465.29.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Penumbra was 4996.33. The lowest was 4130.00. And the median was 4449.50.


Penumbra Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Penumbra's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Cyclically Adjusted FCF per Share Chart

Penumbra Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.03

Penumbra Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.75 -7.03 -3.80 -1.03 1.10

Competitive Comparison of Penumbra's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Penumbra's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Penumbra's Cyclically Adjusted Price-to-FCF falls into.


;
;

Penumbra Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Penumbra's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=18.546/134.9266*134.9266
=18.546

Current CPI (Mar. 2025) = 134.9266.

Penumbra Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -3.914 100.684 -5.245
201509 -9.510 100.392 -12.781
201512 -5.190 99.792 -7.017
201603 -1.662 100.470 -2.232
201606 -4.824 101.688 -6.401
201609 1.346 101.861 1.783
201612 -10.314 101.863 -13.662
201703 -0.596 102.862 -0.782
201706 -0.827 103.349 -1.080
201709 3.467 104.136 4.492
201712 -3.032 104.011 -3.933
201803 3.988 105.290 5.111
201806 -1.174 106.317 -1.490
201809 4.908 106.507 6.218
201812 2.091 105.998 2.662
201903 -2.427 107.251 -3.053
201906 -0.977 108.070 -1.220
201909 7.692 108.329 9.581
201912 -1.670 108.420 -2.078
202003 -10.350 108.902 -12.823
202006 -18.523 108.767 -22.978
202009 -4.700 109.815 -5.775
202012 -3.193 109.897 -3.920
202103 -9.998 111.754 -12.071
202106 -3.498 114.631 -4.117
202109 16.755 115.734 19.533
202112 -9.192 117.630 -10.544
202203 -4.872 121.301 -5.419
202206 -23.441 125.017 -25.299
202209 -10.216 125.227 -11.007
202212 -1.141 125.222 -1.229
202303 4.260 127.348 4.514
202306 5.579 128.729 5.848
202309 12.219 129.860 12.696
202312 14.082 129.419 14.681
202403 13.682 131.776 14.009
202406 8.536 132.554 8.689
202409 25.640 133.029 26.006
202412 23.293 133.157 23.603
202503 18.546 134.927 18.546

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Penumbra  (MEX:PEN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Penumbra's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4911.82/1.10
=4,465.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Penumbra was 4996.33. The lowest was 4130.00. And the median was 4449.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Penumbra Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Penumbra's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.